Showing results (121-130 of 193) with videos related to
Sort By:
Pageof 20
Journal of Wound Care|February 15, 2014
Skin necrosis due to fluindione treatment: a rare but serious complicationK Beqqal, M H Horellou, A Philippe, et al.AIDS (London, England)|July 9, 1999
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimenM Renaud, C Katlama, A Mallet, et al.Journal of Clinical Microbiology|May 6, 2011
Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimationsM Wirden, R Tubiana, S Fourati, et al.The British Journal of Dermatology|May 14, 2016
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesionsA Desnoyer, N Dupin, L Assoumou, et al.Annales De Dermatologie Et De Venereologie|June 6, 2018
[Pemphigus and herpes: Multicentre survey and literature review]M Merlant, V Seta, P Bernard, et al.Annales De Dermatologie Et De Venereologie|September 25, 1998
[Pruritus and the hepatitis C virus. The MULTIVIRC Unit]H Dega, C Francès, N Dupin, et al.Journal of Clinical Microbiology|March 20, 2009
Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypesM Wirden, R Tubiana, F Marguet, et al.The European Respiratory Journal|June 16, 2006
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertensionM C Tamby, M Humbert, P Guilpain, et al.Immunology Letters|April 15, 1999
Restoration of the immune system with anti-retroviral therapyB Autran, G Carcelaint, T S Li, et al.HIV Medicine|May 26, 2010
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patientsS Lambert-Niclot, N Machouf, G Peytavin, et al.Pageof 20